BTRX-335140

CAS No. 2244614-14-8

BTRX-335140( CYM-53093 )

Catalog No. M24021 CAS No. 2244614-14-8

BTRX-335140 is a potent and selective, orally active κ opioid receptor (KOR) antagonist, has antagonist activity for κOR, μOR and δOR with IC50 values of 0.8 nM, 110 nM, and 6500 nM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 169 In Stock
5MG 285 In Stock
10MG 478 In Stock
25MG 860 In Stock
50MG 1575 In Stock
100MG 2214 In Stock
200MG 2997 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BTRX-335140
  • Note
    Research use only, not for human use.
  • Brief Description
    BTRX-335140 is a potent and selective, orally active κ opioid receptor (KOR) antagonist, has antagonist activity for κOR, μOR and δOR with IC50 values of 0.8 nM, 110 nM, and 6500 nM, respectively.
  • Description
    BTRX-335140 is a potent and selective, orally active κ opioid receptor (KOR) antagonist, has antagonist activity for κOR, μOR and δOR with IC50 values of 0.8 nM, 110 nM, and 6500 nM, respectively. BTRX-335140 can distribute well into the CNS. ADMET (absorption, distribution, metabolism, excretion, and toxicity) . BTRX-335140 endows with favorable in vitro ADMET and in vivo pharmacokinetic profiles and medication-like duration of action in rats.
  • In Vitro
    Navacaprant (BTRX-335140) (0-10 μM; 4 h) shows selective antagonist activity towards Kappa Opioid Receptor. Cell Viability Assay Cell Line:OPRK1-BLA U2OS cells Concentration:0-10 μM Incubation Time:4 hours Result:Exibited antagonist activity to KOR, DOR and MOR with IC50 values of 0.8, 110 and 6500 nM respectively, and showed selective antagonist activity to KOR.
  • In Vivo
    Navacaprant (BTRX-335140) (0.01-3 mg/kg; p.o. once) reduces U69,593- stimulated plasma prolactin secretion to levels of without U69,593 treatment.Navacaprant (BTRX-335140) (1 mg/kg; i.p. once) blocks U-50488-induced antinociception from hot water.Animal Model:Rat PRL model Dosage:0.01, 0.03, 0.1, 0.3, 1 and 3 mg/kg Administration:Oral gavage; 0.01-3 mg/kg onceResult:Effectively decreased the high level prolactin caused by U69,593 even at a dosage of 0.1 mg/kg.Animal Model:Adult male ICR mice with tail dipped into 50°C hot water Dosage:1 mg/kg Administration:Intraperitoneal injection; 1 mg/kg once Result:Blocked the U-50488-induced antinociception at 1 h but not at 24 h pretreatment time and showed a medication-like duration of action in blocking the KOR.
  • Synonyms
    CYM-53093
  • Pathway
    Endocrinology/Hormones
  • Target
    Opioid Receptor
  • Recptor
    δ-opioid receptor|κ-opioid receptor|μ-opioid receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2244614-14-8
  • Formula Weight
    453.55
  • Molecular Formula
    C25H32FN5O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:16.67 mg/mL (36.75 mM; Need ultrasonic)
  • SMILES
    CCc1cc2c(C)c(-c3nc(C)no3)c(N(CC3)CCC3NC3CCOCC3)nc2c(F)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Guerrero M, et al. Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140). J Med Chem. 2019 Feb 28;62(4):1761-1780.
molnova catalog
related products
  • ORL1 antagonist 1

    ORL1 antagonist 1 is an o antagonist of pioid receptor-like 1 (ORL1) (IC50 of 61 nM).

  • Loperamide hydrochlo...

    Loperamide HCl is an opioid-receptor agonist used as long-acting synthetic antidiarrheals.

  • Nociceptin (1-13), a...

    Nociceptin (1-13), amide is a potent ORL1 (OP4) receptor agonist with a pEC50 of 7.9 for mouse vas deferens and a Ki of 0.75 nM for binding to rat forebrain membranes.